1. Introduction {#s0005}
===============

Schizophrenia is a devastating and chronic neuropsychiatric disorder that affects nearly 1% of the world\'s population ([@bb0065]). Much of the evidence shows that cognitive deficits in schizophrenia are heterogeneous, ranging from pervasive generalized dysfunction through patchy focal disorders to mild focal deficits or nearly normal performance ([@bb0020], [@bb0085], [@bb0070], [@bb0135], [@bb0005], [@bb0190], [@bb0215]). In addition, evidence from cross-sectional ([@bb0090], [@bb0105], [@bb0160]) and longitudinal studies ([@bb0095]) has consistently shown that cognitive impairment in schizophrenia is a more stable and robust correlate of functional impairment than clinical symptoms. Because the ultimate aim of cognitive enhancement is to support functional recovery, cases where neuropsychological (NP) performance is normal may lead to these cases being regarded as having minimal intervention potential ([@bb0160]). In the study by [@bb0160], they found that NP normal cases still show deficits in several domains of everyday functioning milestones. Hence, they thought the classifications of NP normality may provide a meaningful categorization for the concept of outcome in the recovery model. In addition, a population-representative longitudinal study found that NP normal cases showed a decline on the digit symbol coding test, suggesting that a decline in processing speed is a core feature of schizophrenia ([@bb0175]). These results suggest that identification of NP normality could reduce the likelihood of false negative judging in their outcomes. Recently, [@bb0115] validated two neurocognitive subtypes of schizophrenia using the MATRICS Consensus Cognitive Battery (MCCB), for which the criteria for assignment to cognitively normal range (CNR) groups were based on previous studies using MCCB ([@bb0145], [@bb0150], [@bb0180]).CNR schizophrenia patients may be largely indistinguishable from normal-range controls, with the exception of processing speed performance. In contrast with CNR, below normal range (BNR) may be indistinguishable from low-performing controls even in terms of processing speed.

Based on the findings of the aforementioned studies, it is reasonable that we hypothesize the same neurocognitive subtypes of schizophrenia with differential illness characteristics in patients of Han Chinese ethnicity with schizophrenia. Unfortunately, we could not find any published empirical papers to examine this hypothesis. The aim of this study was to validate the CNR and BNR subtypes in chronically hospitalized patients with schizophrenia.

2. Materials and methods {#s0010}
========================

2.1. Participants {#s0015}
-----------------

The sample came from two studies. From one part of the sample, 76 subjects were recruited from a study on cognitive impairment in stable, hospitalized patients with schizophrenia (the Cognitive Function study), whereas from another part of the sample, 55 subjects were recruited from a study on the follow-up of mental functions in stable, hospitalized patients with schizophrenia (the Mental Function study). The criteria of inclusion and exclusion of the subjects were the same in both studies. In total, 131 patients of Han Chinese ethnicity with schizophrenia, aged 20--65, who had been diagnosed according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) participated in this study. Subjects were excluded from this study if their scores on the Mini Mental Status Examination (MMSE) were below 20, if they refused to receive the evaluation or had an acute psychotic episode that required transfer for admission, or if they had the presence of an organic brain disorder, brain injury with post-traumatic amnesia, mental retardation, movement disorders, or recent (within 6 months) substance dependence or electroconvulsive therapy.

2.2. Measures {#s0020}
-------------

Six cognitive domains according to MATRICS-NIMH suggestions about the fundamental dimensions of cognitive deficit in schizophrenia ([@bb0190]) were included in this study. The seventh cognitive domain, IQ, suggested by [@bb0080], was also included. In addition, to judge if a patient\'s basic cognitive function was qualified as a subject for taking various tests reliably in this study, we also administered a screen test.

We selected the tests for measuring seven different cognitive domains, and we constructed them by referencing the suggestions and the results in [@bb0190]. The final results of the test selection in this study were:1) the Speed of Processing: the Digit Symbol Substitution Test (DSS) in the Chinese Version of the Wechsler Adult Intelligence Test, Third Version (CV-WAIS-III) ([@bb0040]) and the A Form and the B Form of the Trial Making Test (TMA & TMB) ([@bb0165]); 2) the Attention: the Conners Continuous Performance Test, 3rd Edition (Conners CPT 3) ([@bb0060]); 3) the Working Memory: the Working Memory Index (WMI) in the CV-WAIS-III; 4) the Verbal Memory: the Logistic Memory Test (LG) in the Chinese Version of the Wechsler Memory Test, Third Version (CV-WMS-III) ([@bb0125]); 5) the Visual Memory: the Visual Reproduction (VR) Test in the CV-WMS-III; 6) Reasoning and Problem Solving: the Modified Card Sorting Test (MCST) ([@bb0185]) and the Semantic Associated Verbal Fluency Test (SAVFT) ([@bb0120]); 7) the Full-Scaled IQ (FSIQ), which is a short-form version of the CV-WAIS-III composed of four subtests including the Information, the Arithmetic, the Digit Span, and the Block Design ([@bb0050]). The basic cognitive function was assessed with the Chinese version ([@bb0100]) of the Mini-Mental State Examination (MMSE) ([@bb0075]). A total of 21 measured cognitive indexes were used as variables for the partitioning of neurocognitive subtypes.

Psychopathology was assessed with the Chinese version ([@bb0045]) of the Positive and Negative Syndrome Scale (CV-PANSS) ([@bb0140]). Regarding social function, the Chinese version of the Social Function Scale (CV-SFS) was used to assess the seven dimensions of the social function of subjects including withdrawal, interpersonal, independence-competence, independence-performance, pro-social, recreation, and employment ([@bb0210]).

2.3. Rating of NP impairment {#s0025}
----------------------------

Because there is no Chinese version of the MCCB in Taiwan, we could not follow the criteria for assignment to CNR and BNR, as was followed in the study by [@bb0115]. We reviewed three strategies for the designation of impairment in the study of [@bb0200]: the Individual Profile Rating (IPR) procedure presented by [@bb0155], the definition of Clinically Significant Cognitive Impairment (CSCI) suggested by [@bb0195], and the Global Deficit Score (GDS) approach adopted by [@bb0110] and [@bb0015]. We decided to use the GDS method as the criterion for validating the CNR and BNR according to the findings of previous studies, including: 1) the IPR was less sensitive to impairment ([@bb0200]); 2) the GDS and CSCI criteria had substantial to outstanding convergence across all diagnostic groups ([@bb0200]); and 3) the GDS method was relatively unaffected by modifications in test batteries ([@bb0110], [@bb0015]).

The GDS method begins by converting *T* scores to deficit scores that reflect the presence and severity of impairment. *T* scores greater than 40 represented no impairment (deficit score = 0), whereas a deficit score of 1 reflects mild impairment (*T* scores =39to 35), a deficit score of 2 reflects mild to moderate impairment (*T* scores =34 to 30), a deficit score of 3 reflects moderate impairment (*T* scores =29 to 25), a deficit score of 4 reflects moderate to severe impairment (*T* scores =24 to 20), and a deficit score of 5 reflects severe impairment (*T* scores \<20). Deficit scores on all tests were then averaged to create the GDS. Results in [@bb0110] and [@bb0015] showed that a GDS greater than or equal to 0.5 has accurately predicted the expert clinical rating of overall impairment. In this study, we adopted GDS 0.5 to be the cutoff of NP impairment.

2.4. Procedures {#s0030}
---------------

The Cognitive Function study began in September 2013 and was completed in August 2015. The study was approved by the Institutional Review Board of the Kaohsiung Municipal Kai-Syuan Psychiatric Hospital. All subjects were screened and verified by meeting the study criteria of two professionals with extensive experience in clinical practice and research (CSK, Ph.D., and LKC, M.Sc., both of whom are certified clinical psychologists). All neurocognitive function indexes were examined by two qualified clinical psychologists (NCH and TCP, both M.Sc.).

The Mental Function study began in July 2008 and was completed in June 2013. This study was approved by the Yuli Branch of the Taipei Veterans General Hospital Institutional Review Board. All subjects were screened and verified by meeting the study criteria of one professional with extensive experience in clinical practice and research (CJY, M.D., certified psychiatrist). All neurocognitive function indexes were examined by one qualified clinical psychologist (CSK., Ph.D.). The psychopathology was rated by two certified psychiatrists (CJY and PLY). The inter-rater reliability for the CV-PANSS (*k* = 0.85) was established for both raters. The CV-SFS scores were provided by senior nurses who were in charge of the subjects, both of whom have received the required training for the CV-SFS from CSK before the study had begun. Written informed consent was obtained after the procedures were fully explained to the patients.

2.5. Statistical analysis {#s0035}
-------------------------

### 2.5.1. Generalized association plot (GAP) {#s0040}

We used GAP to explore the neurocognitive subtypes in 131 patients with schizophrenia. The GAP ([@bb0025], [@bb0030], [@bb0035], [@bb0170]) is an information visualization environment (<http://gap.stat.sinica.edu.tw.autorpa.tcu.edu.tw>) for extracting important information embedded in a raw data matrix and proximity matrices for variables as well as for subjects. Although factor analysis and cluster analysis are corresponding conventional statistical tools, respectively, to the GAP correlation matrix map and the Euclidean distance matrix map, there is no counterpart for the GAP data matrix map, which is the most important and unique feature of GAP. Factor analysis depends on a sophisticated statistical model to summarize information in the correlation matrix, but GAP merely utilizes the sorted correlation matrix map to reveal similar messages. The major difference is that GAP displays the whole correlation matrix and the raw data matrix without sacrificing any information ([@bb0130]). There were two reasons we used the GAP in this study. First, the GAP provides five levels of integral information, and three matrix maps are integrated to retrieve these five levels of information. Second, [@bb0130] showed the usefulness of the GAP method in sub-grouping Han Chinese ethnicity schizophrenic patients based on their PANSS ratings and clustering symptom-dimensions based on their relative PANSS scoring structure on admission. We believe that the rationale of the GAP method is also suitable for partitioning patients into subgroups according to their neurocognitive functions in the same social and cultural context.

### 2.5.2. Other statistical analyses {#s0045}

The Statistical Package for the Social Sciences (SPSS) was used for other statistical analyses. The Independent *t* test was used to test the differences in means, and the chi-square test was used to test the differences in frequencies between groups in the sample for individual indexes. The significance level for a two-sided test was set at *α* = 0.05. For comparing seven cognitive domains with norms of normal controls, we computed Cohen\'s d effect size ([@bb0055]) for differences between each patient group\'s mean scores across individual indexes and cognitive domains. In addition, for validating the CNR and BNR in the sample, we also computed the GDS of each patient\'s group.

3. Results {#s0050}
==========

3.1. Gap {#s0055}
--------

[Fig. 1](#f0005){ref-type="fig"} shows the order of 21 cognitive function indexes and two visible dark red blocks along the main diagonal of a correlation matrix map. When the patients\' relationship structures represented by the Euclidean distance matrix were sorted, two blocks along the main diagonal were identified visually as Group 1 (54 cases) and Group 2 (77 cases).Fig. 1Clustering of neurocognitive functions and schizophrenic patients using the generalized association plots (GAP).The proximity of between cognitive function correlation coefficients for 21 cognitive functions indexes is displayed as a color map in the upper figure. One hundred and thirty-one patients were ordered and displayed by GAP based on the matrix of between-patient Euclidean distance in the lower right figure. Two groups of patients were identified with their within-group distances summarized in a clustering tree. The Cognitively Normal Range (CNR) contains fifty-four patients and the Below Normal Range (BNR) contains seventy-seven patients. The raw cognitive functions data for 131 schizophrenic patients with 21 indexes were permuted using the aforementioned respective orders for cognitive functions and for patents, and then displayed as a color map in the lower left figure. The complete structure of cognitive functions and patients subgroups together with their interactions was jointly comprehended through visualization.Fig. 1

3.2. Demographics, clinical characteristics, and description of individualized cognitive measures {#s0060}
-------------------------------------------------------------------------------------------------

The left-hand columns of [Table 1](#t0005){ref-type="table"} show the original data of the demographic features and the means and standard deviations from 21 cognitive function indexes of two groups sorted by the GAP. Except for gender (*x*^2^ = 0.34, *p* \> .05), education (*t* = −1.01, *p* \> .05) and CPTd (*t* = 0.38, *p* \> .05), there were significant differences between Group 1 and Group 2 in Age (*t* = 2.21, *p* \< .05) and all other cognitive function indexes including MCST p (*t* = 5.69, *p* \< .001), TMB (*t* = 17.73, *p* \< .001), TMA (*t* = 7.89, *p* \< .001), CPTp (*t* = 3.54, *p* \< .01), LGTII (*t* = −3.13, *p* \< .01), LGT (*t* = −3.70, *p* \< .001), LGII (*t* = −3.83, *p* \< .001), LGI (*t* = −5.00, *p* \< .001), SAVFT (*t* = −5.63, *p* \< .001), VRI (*t* = −3.99, *p* \< .001), VRII (*t* = −4.43, *p* \< .001), DSS (*t* = −5.07, *p* \< .001), MCSTc (*t* = −7.44, *p* \< .001), BD (*t* = −5.92, *p* \< .001), WMI (*t* = −9.01, *p* \< .001), DS (*t* = −6.98, *p* \< .001), ARI (*t* = −8.22, *p* \< .001), FSIQ (*t* = −9.25, *p* \< .001), INF (*t* = −6.89, *p* \< .001), and MMSE (*t* = −7.70, *p* \< .001).Table 1Descriptive statistics of the 131 subjects sample.Table 1BNRCNRP valueBNRCNRP valueOriginal DataZ-score DataSample size7754--7754--Age48.73 ± 10.8244.50 ± 10.73\<0.05[a](#tf0005){ref-type="table-fn"}------Education10.74 ± 2.5811.67 ± 2.95\>0.05[a](#tf0005){ref-type="table-fn"}------Gender (male:female)49:2837:17\>0.05[b](#tf0010){ref-type="table-fn"}------MCSTp19.97 ± 14.667.04 ± 9.58\<0.001[a](#tf0005){ref-type="table-fn"}4.78 ± 4.071.15 ± 2.78\<0.001[a](#tf0005){ref-type="table-fn"}TMb165.47 ± 20.1592.24 ± 28.10\<0.001[a](#tf0005){ref-type="table-fn"}2.28 ± 0.460.56 ± 0.65\<0.001[a](#tf0005){ref-type="table-fn"}TMa74.03 ± 17.8249.37 ± 18.51\<0.001[a](#tf0005){ref-type="table-fn"}3.14 ± 1.301.29 ± 1.35\<0.001[a](#tf0005){ref-type="table-fn"}CPTp5.81 ± 8.261.61 ± 3.34\<0.01[a](#tf0005){ref-type="table-fn"}3.27 ± 2.041.08 ± 1.96\<0.001[a](#tf0005){ref-type="table-fn"}CPTd.62 ± .44.60 ± .38\>0.05[a](#tf0005){ref-type="table-fn"}0.26 ± 0.930.34 ± 0.85\>0.05[a](#tf0005){ref-type="table-fn"}LGTII5.66 ± 3.007.27 ± 2.77\<0.01[a](#tf0005){ref-type="table-fn"}−1.45 ± 1.00−0.91 ± 0.92\<0.001[a](#tf0005){ref-type="table-fn"}LGT5.31 ± 3.157.53 ± 3.69\<0.001[a](#tf0005){ref-type="table-fn"}−1.56 ± 1.05−0.82 ± 1.23\<0.001[a](#tf0005){ref-type="table-fn"}LGII4.91 ± 3.026.98 ± 3.08\<0.001[a](#tf0005){ref-type="table-fn"}−1.70 ± 1.01−1.01 ± 1.03\<0.001[a](#tf0005){ref-type="table-fn"}LGI4.89 ± 2.687.43 ± 3.12\<0.001[a](#tf0005){ref-type="table-fn"}−1.70 ± 0.89−0.86 ± 1.04\<0.001[a](#tf0005){ref-type="table-fn"}SAVFT23.27 ± 7.5131.63 ± 9.46\<0.001[a](#tf0005){ref-type="table-fn"}−1.75 ± 0.75−0.92 ± 0.94\<0.001[a](#tf0005){ref-type="table-fn"}VRI5.26 ± 2.697.29 ± 3.08\<0.001[a](#tf0005){ref-type="table-fn"}−1.58 ± 0.90−0.90 ± 1.03\<0.001[a](#tf0005){ref-type="table-fn"}VRII5.74 ± 2.147.54 ± 2.47\<0.001[a](#tf0005){ref-type="table-fn"}−1.42 ± 0.71−0.82 ± 0.82\<0.001[a](#tf0005){ref-type="table-fn"}DSS5.83 ± 2.718.48 ± 3.26\<0.001[a](#tf0005){ref-type="table-fn"}−1.39 ± 0.90−0.51 ± 1.08\<0.001[a](#tf0005){ref-type="table-fn"}MCSTc1.85 ± 1.574.31 ± 2.23\<0.001[a](#tf0005){ref-type="table-fn"}−2.25 ± 0.99−0.70 ± 1.40\<0.001[a](#tf0005){ref-type="table-fn"}BD6.39 ± 2.319.15 ± 3.03\<0.001[a](#tf0005){ref-type="table-fn"}−1.20 ± 0.77−0.28 ± 1.01\<0.001[a](#tf0005){ref-type="table-fn"}WMI78.27 ± 10.7696.91 ± 12.83\<0.001[a](#tf0005){ref-type="table-fn"}−1.45 ± 0.72−0.21 ± 0.86\<0.001[a](#tf0005){ref-type="table-fn"}DS7.48 ± 2.3310.80 ± 3.11\<0.001[a](#tf0005){ref-type="table-fn"}−0.84 ± 0.780.27 ± 1.04\<0.001[a](#tf0005){ref-type="table-fn"}ARI5.11 ± 1.858.13 ± 2.35\<0.001[a](#tf0005){ref-type="table-fn"}−1.63 ± 0.62−0.62 ± 0.78\<0.001[a](#tf0005){ref-type="table-fn"}FSIQ79.67 ± 10.1797.78 ± 12.14\<0.001[a](#tf0005){ref-type="table-fn"}−1.36 ± 0.68−0.15 ± .81\<0.001[a](#tf0005){ref-type="table-fn"}INF6.85 ± 2.0610.06 ± 3.27\<0.001[a](#tf0005){ref-type="table-fn"}−1.05 ± 0.690.02 ± 1.09\<0.001[a](#tf0005){ref-type="table-fn"}MMSE24.84 ± 2.7227.98 ± 1.50\<0.001[a](#tf0005){ref-type="table-fn"}−1.10 ± 1.090.15 ± 0.60\<0.001[a](#tf0005){ref-type="table-fn"}[^4][^5]

To verify whether the profiles of the neurocognitive function of Group 1 and Group 2 are comparable with the CNR and BNR of patients with schizophrenia, we transformed the original data in the left-hand columns into the Z-scores data presented in the right-hand columns of [Table 1](#t0005){ref-type="table"} by calculating adequate normal Taiwanese adult norms. The right-hand columns of [Table 1](#t0005){ref-type="table"} show the Z-score data of the means and standard deviations from 21 cognitive function indexes of two groups sorted by the GAP. Similarly, except for (*t* = −.47, *p* \> .05), there were significant differences between Group 1 and Group 2 in all other neurocognitive function indexes.

[Fig. 2](#f0010){ref-type="fig"} shows the recognizable profiles of neurocognitive function between Group 1 and Group 2. The right-hand columns of [Table 1](#t0005){ref-type="table"} further revealed Z scores with significant differences between CNR and BNR. For CNR, the absolute values of Z scores ranged from 0.34 of CPTd to1.29 of TMa, compared with Z scores of BNR from 0.26 of CPTd to 4.78 of MCSTp. Because the higher scores on MSCTp, TBa, TBb, CPTp indicated worse performance, we reversed the values of these indexes in [Fig. 2](#f0010){ref-type="fig"} for the purpose of comparisons between CNR and BNR from an impairment view. [Table 1](#t0005){ref-type="table"} and [Fig. 2](#f0010){ref-type="fig"} support Group 1 and Group 2 in this study and were comparable with CNR and BNR, respectively.Fig. 2Profiles of cognitive function indexes in CNR and BNRNote. MCSTp = Modified Card Sorting Test, perseveration error; TMb = Trial Making Test, B form; TMa = Trial Making Test, A form; CPTp = Continuous Performance Test, perseveration error; CPTd = Continuous Performance Test, dprime; LGTII = Logistic Theme delayed recall; LGTI = Logistic Theme immediate recall; LGII = Logistic delayed recall; LGI = Logistic immediate recall; SAVFT = Semantic Association Verbal Fluency Test; VRI = Visual Reproduction immediate recall; VRII =Visual Reproduction delayed recall; DSS = Digit Symbol Substitution Test; MCSTc = Modified Card Sorting Test, category; BD = Block Design Test; WMI = Working Memory Index; DS = Digit Span Test; ARI = Arithmetic Test; FSIQ = Full Scaled IQ; INF = Information Test; MMSE = Mini Mental Status Examination.Fig. 2

3.3. Description of social function, psychopathology, and other clinical features {#s0065}
---------------------------------------------------------------------------------

[Table 2](#t0010){ref-type="table"} shows the original data of the demographic features and the mean and standard deviations of clinical features, psychopathology, and social function of this sample. There were no significant differences on gender (*x*^2^ = 2.64, *p* \> .05), Age(*t* = −.22, *p* \> .05), duration of illness(*t* = −1.78, *p* \> .05), chlorpromazine equivalents (CPZE) (*t* = 0.62, *p* \> .05), negative symptoms (*t* = 0.56, *p* \> .05), general symptoms (*t* = −.56, *p* \> .05), CV-PANSS (*t* = −.99, *p* \> .05), and interpersonal (*t* = 1.82, *p* \> .05) between CNR and BNR. CNR was later than BNR on age at first onset (*t* = 2.39, *p* \< .05), education (*t* = 3.76, *p* \< .001), withdrawal score (*t* = 2.71, *p* \< .01), independence-competence score (*t* = 3.37, *p* \< .01), independence-performance score (*t* = 4.33, *p* \< .001), recreation score (*t* = 4.05, *p* \< .001), pro-social score (*t* = 3.23, *p* \< .01), employment score (*t* = 3.99, *p* \< .001), and CV-SFS score (*t* = 4.32, *p* \< .001). BNR was higher than CNR on positive symptoms (*t* = −2.39, *p* \< .05).Table 2Descriptive statistics of the 55 subjects sample.Table 2CNRBNRP valueSample size2629--Age43.35 ± 5.0243.93 ± 10.90\>0.05[a](#tf0015){ref-type="table-fn"}Education12.40 ± 1.9610.25 ± 1.98\<0.001[a](#tf0015){ref-type="table-fn"}Age at first onset24.30 ± 8.2120.16 ± 3.74\<0.05[a](#tf0015){ref-type="table-fn"}Duration of illness19.05 ± 7.9423.77 ± 9.85\>0.05[a](#tf0015){ref-type="table-fn"}CPZE885.50 ± 670.53759.24 ± 723.35\>0.05[a](#tf0015){ref-type="table-fn"}Gender (male:female)10:1617:12\>0.05[b](#tf0020){ref-type="table-fn"}Negative symptom score19.75 ± 5.8718.76 ± 6.22\>0.05[a](#tf0015){ref-type="table-fn"}Positive symptom score14.70 ± 7.0919.97 ± 7.84\<0.05[a](#tf0015){ref-type="table-fn"}General symptom score34.95 ± 11.2536.55 ± 8.86\>0.05[a](#tf0015){ref-type="table-fn"}PANSS total score69.40 ± 22.6175.28 ± 18.53\>0.05[a](#tf0015){ref-type="table-fn"}Social FunctionWithdrawal4.35 ± 1.603.03 ± 1.72\<0.01[a](#tf0015){ref-type="table-fn"}Interpersonal7.70 ± 1.596.72 ± 2.00\>0.05[a](#tf0015){ref-type="table-fn"}Independence-competence11.10 ± 3.438.24 ± 2.52\<0.01[a](#tf0015){ref-type="table-fn"}Independence-performance10.15 ± 3.735.86 ± 3.17\<0.001[a](#tf0015){ref-type="table-fn"}Recreation11.85 ± 3.807.55 ± 3.54\<0.001[a](#tf0015){ref-type="table-fn"}Prosocial5.70 ± 3.482.83 ± 2.74\<0.01[a](#tf0015){ref-type="table-fn"}Employment6.95 ± 1.994.07 ± 2.76\<0.001[a](#tf0015){ref-type="table-fn"}Total57.80 ± 16.5138.31 ± 14.81\<0.001[a](#tf0015){ref-type="table-fn"}[^6][^7]

In comparison with the CNR, the BNR patients were older, and have an earlier illness onset, an increased severity of positive symptoms, and a greater severity of functional disability. According to the Taiwanese Schizophrenic Norms of CV-SFS, the scores of CV-SFS can be divided into four levels, reflecting the patient\'s level of social function. Scores above 71 are superior, with scores ranging from 70 to 52 being high, scores ranging from 51 to34 being middling, and scores below 33 being low. In this study, CNR with a mean score of 57.8 was at a high level, while in contrast, BNR with a mean score of 38.31 was in the middle level of social function.

3.4. Validation of CNR and BNR by Cohen\'s d effect size and the GDS {#s0070}
--------------------------------------------------------------------

### 3.4.1. Cohen\'s d effect size of cognitive indexes and cognitive domains {#s0075}

For BNR patients, the effect sizes ranged from *d* = 0.29 to 2.26 across the16 individual indexes and from 1.12 to 2.39 across the seven cognitive domains. For CNR patients, the resulting effect sizes ranged from *d* = 0.02 to 1.01 across the 16 individual indexes and from 0.18 to 0.93 across the seven cognitive domains. [Fig. 3](#f0015){ref-type="fig"} reveals the effect sizes pooled root mean square according to the cognitive domains across the two groups of patients.Fig. 3ES pooled root mean square by domain.Note: Neurocognitive function indexes together with the cognitive domains they comprise. Attention: CPTd, CPTp; Working Memory: WMI; Executive Function: MCSTc, MCSTp, SAVFT; Verbal Memory: LGI, LGII, LGTI, LGTII; Visual Memory: VRI, VRII; Processing Speed: TMa, TMb, DSS; Full-scaled IQ: FSIQ. Indexes without used to compose of cognitive domains include BD, INF, DS, ARI, and MMSE.Fig. 3

### 3.4.2. The GDS {#s0080}

The same cognitive indexes were used to compute the GDS as were used to compute Cohen\'s d effect size. For BNR patients, *T* scores ranged from *T* = 2.2 to 52.6 across the 16 individual indexes. One cognitive index had deficit scores of 0, five indexes had deficit scores of 1, five indexes had deficit scores of 2, two indexes had deficit scores of 3, and three indexes had deficit scores of 5. The GDS of BNR is 2.25. For CNR patients, *T* scores ranged from *T* = 37.1 to 53.4 across the 16 individual indexes. Three cognitive indexes have deficit scores of 1, and thirteen indexes had deficit scores of 0. The GDS of CNR is 0.19.

4. Discussions {#s0085}
==============

We applied GAP analyses to neurocognitive performance data from a median sample (*n* = 131) of chronically hospitalized patients with schizophrenia. The GAP analyses revealed the existence of two patient subtypes. The post hoc test using the independence t-test showed that there were significant differences between the two sub-types except for the CPTd index. Group 1 was characterized by severe neurocognitive impairments across all cognitive indexes except for the CPTd index and was referred to as the BNR subtype; in contrast, Group 2 displayed relatively better cognitive performance in comparison to the BNR subtype and was referred to as the CNR subtype. By means of an investigation of the magnitude of the cognitive domain, for BNR patients, the effect sizes across the seven cognitive domains were all higher than 1 ranging from *d* = 1.12 to *d* = 2.39. For CNR patients, the resulting effect sizes across the same cognitive domains were all lower than 1 ranging from *d* = .18 to *d* = 0.93. For BNR patients, the GDS of 2.25 reflected a mild to moderate NP impairment. For CNR patients, the GDS of 0.19, which was smaller than the cutoff of 0.5, reflected no NP impairment. These analyses confirmed the utility of the GAP method in elucidating homogeneous subtypes in patients of Han Chinese ethnicity with schizophrenia, who were characterized by significant differences in neurocognitive impairment (for example, above a 15-point difference in FSIQ). The results are consistent with a recent study using MCCB ([@bb0115]).

We also noticed that the aforementioned studies and the current study all used the cognitive domain strategy. One advantage of the cognitive domain strategy is that it could reduce the likelihood of false positive findings obtained with individual putative NP or neurophysiological measures ([@bb0205]). In this study, we not only took the cognitive domain strategy, but also clustered patients according to their performances on these cognitive domains. We thought that there was another advantage in doing so: additional clustering of patients by neurocognitive measures could connect them to different outcomes in different cultural contexts. This will help clinical practitioners on the front lines to identify patients by their outcomes in routine practice works and to provide patients with suitable examinations, therapy, or care. In summary, by combining the current study and the study of Heinrichs et al., we found that the CNR and the BNR could be identified across different patient populations, different neurocognitive measures tools, and different partitioning groups methods. This implied that these two subtypes were stable and differential neurocognitive domain profiles. Recently, [@bb0175] found that there is substantial NP decline in schizophrenia from the premorbid to the post-onset period, but the extent and developmental progression of decline vary across mental functions. One important claim in the study of Meier et al. was that average to above-average NP test performance in a subset of adults diagnosed with schizophrenia cannot be used to infer that NP decline had not occurred. However, they also proposed a limitation for this claim, because a relatively small group size prevented them from conducting an in-depth exploration of heterogeneity in NP decline. We thought that the fact that this study has an important application to clear this limitation in the near future, for two reasons: first, this study validated the fact that both CNR and BNR patients all had a medium group size; and second, most patients of both groups were evaluated using same tests 3 years ago. We believe that the following data analysis will supplement the limitation in the study of Meier et al.

4.1. Strength of the study {#s0090}
--------------------------

There were three strengths in this study. First, taking the cognitive domain strategy lets researchers select suitable neurocognitive measures according to their own clinical and cultural contexts. This effectively increased many opportunities for comparison among the studies on cognitive domain basis in schizophrenia from different social and cultural contexts. Second, we used the GAP method, which is a dimension-free statistical visualization method preserving every single piece of numerical information in the final output. By using GAP analysis, clinical researchers can easily comprehend and summarize every piece of information contained in a study data set ([@bb0130]). Third, the current study was the first paper validated where there were both CNR and BNR patients of Han Chinese ethnicity with schizophrenia. These findings will facilitate development on related studies in the same clinical and cultural context in the future.

4.2. Limitations {#s0095}
----------------

There were two limitations in the present study, both of which limit the generalizability of the results. The major limitation was on the diversity of sample. Compared with studies of [@bb0160] and [@bb0115], there was no normal control group in the present study. Therefore, we used the normative comparison standard strategy ([@bb0165]) to judge the impairment level of subjects on individualized cognitive measures by comparing the scores of subjects with reliable norms of Taiwanese normal controls for the measures. The minor limitation was on the assessment tools of neurocognitive domains. We noticed that many studies used MCCB as a tool for assessing subjects\' neurocognitive domains. However, there is no Chinese version of the MCCB in Taiwan. In the future, we hope to compare directly the MCCB with the tools that we used in this study.

Role of the funding source {#s0100}
==========================

This research was funded by the Ministry of Science and Technology, R.O.C. (project grant NSC-100-2410-H-480-001).

Contributors {#s0105}
============

National Dong Hwu University: Wan-Yu Liu.

Kaohsiung Municipal Kai-Syuan Psychiatric Hospital: Jui-Hua Liu.

Yuli Branch of Taipei Veterans General Hospital: Fang-Hsien Chu, Yung-Cheng Chen, Jen-Yeu Chen, Lein-Yung Ping.

Conflict of interest {#s0110}
====================

All authors declare that they have no conflict of interest.

This work was supported by grants from the Ministry of Science and Technology, R.O.C. Two psychiatrists made specific contributions to earlier stages of this project: J.Y. Chen and L.Y. Ping. We want to thank the staff of the Yuli Branch of the Taipei Veterans General Hospital and the Kaohsiung Municipal Kai-Syuan Psychiatric Hospital for providing patient referrals. We especially thank the patients and other volunteers who participated in this study.

[^1]: Tel.: +886 3 8635104; fax: +886 3 8635300.

[^2]: Tel.: +886 7 7496751x726191; fax: +886 7 7496751.

[^3]: Tel.: +886 7 7513171x2227; fax: +886 7 7712494.

[^4]: P values were computed based on t test by comparing BNR and CNR.

[^5]: P values were computed based on chi-square test by comparing BNR and CNR.

[^6]: P values were computed based on t test by comparing BNR and CNR.

[^7]: P values were computed based on chi-square test by comparing BNR and CNR.
